Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 14 studies | 31% ± 14% | |
lung | 12 studies | 20% ± 6% | |
peripheral blood | 12 studies | 22% ± 5% | |
bone marrow | 4 studies | 19% ± 2% | |
eye | 4 studies | 23% ± 10% | |
intestine | 4 studies | 22% ± 6% | |
adipose | 4 studies | 23% ± 1% | |
kidney | 3 studies | 17% ± 1% | |
liver | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 13109.38 | 21 / 21 | 100% | 60.55 | 504 / 504 |
esophagus | 100% | 11098.91 | 1445 / 1445 | 100% | 56.63 | 183 / 183 |
ovary | 100% | 15753.41 | 180 / 180 | 100% | 49.81 | 430 / 430 |
prostate | 100% | 13815.51 | 245 / 245 | 100% | 50.02 | 502 / 502 |
skin | 100% | 12465.86 | 1809 / 1809 | 100% | 64.49 | 472 / 472 |
thymus | 100% | 16429.91 | 653 / 653 | 100% | 74.52 | 605 / 605 |
uterus | 100% | 16208.52 | 170 / 170 | 100% | 72.99 | 459 / 459 |
breast | 100% | 12579.03 | 459 / 459 | 100% | 67.69 | 1116 / 1118 |
intestine | 100% | 12425.98 | 966 / 966 | 100% | 50.21 | 526 / 527 |
stomach | 100% | 9263.31 | 359 / 359 | 100% | 46.11 | 285 / 286 |
lung | 100% | 11936.22 | 578 / 578 | 100% | 56.54 | 1150 / 1155 |
adrenal gland | 100% | 12438.54 | 258 / 258 | 100% | 45.68 | 229 / 230 |
pancreas | 100% | 6453.69 | 328 / 328 | 99% | 55.47 | 177 / 178 |
kidney | 100% | 9430.82 | 89 / 89 | 99% | 42.74 | 893 / 901 |
brain | 99% | 6496.49 | 2616 / 2642 | 99% | 61.10 | 701 / 705 |
liver | 100% | 5091.78 | 226 / 226 | 97% | 28.20 | 395 / 406 |
adipose | 100% | 11532.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9965.83 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 68.72 | 29 / 29 |
spleen | 100% | 16072.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 60.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.59 | 1 / 1 |
muscle | 100% | 6758.80 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 6083.93 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 60.01 | 79 / 80 |
peripheral blood | 99% | 9968.84 | 916 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_0008380 | Biological process | RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0045657 | Biological process | positive regulation of monocyte differentiation |
GO_0030263 | Biological process | apoptotic chromosome condensation |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0061574 | Cellular component | ASAP complex |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005515 | Molecular function | protein binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ACIN1 |
Protein name | Apoptotic chromatin condensation inducer in the nucleus (Acinus) Apoptotic chromatin condensation inducer 1 |
Synonyms | ACINUS KIAA0670 |
Description | FUNCTION: Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP complexes which bind RNA in a sequence-independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets; ACIN1 confers RNA-binding to the complex. The ASAP complex can inhibit RNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function. Induces apoptotic chromatin condensation after activation by CASP3. Regulates cyclin A1, but not cyclin A2, expression in leukemia cells. . |
Accessions | ENST00000338631.10 [Q9UKV3-2] G3V3B0 ENST00000605057.6 A0A087WYN3 ENST00000262710.5 [Q9UKV3-1] ENST00000557515.5 S4R3H4 ENST00000357481.6 [Q9UKV3-3] ENST00000555352.2 A0A087X0D2 G3V3T3 ENST00000457657.5 ENST00000555566.1 Q9UKV3 E7EQT4 ENST00000473758.5 ENST00000397341.7 [Q9UKV3-3] ENST00000555053.5 [Q9UKV3-5] |